In oral cancer, pancreatic cancer, polymorphic glioblastoma, and hematologic malignancies, Gal-9 expression is increased compared to adjacent non-tumor tissues [84, 90, 91]. This evidence concerns the gene LGALS9 and pancreatic neoplasm.